Characterizing Decision-Making in Anorexia Nervosa Under Conditions of Risk and Ambiguity using Computational Neuroimaging
Characterizing Decision-Making in Anorexia Nervosa Under Conditions of Risk and Ambiguity using Computational Neuroimaging
批准号:
10580198
负责人:
Emily Barkley-Levenson
金额:
$34.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2026-03-31
关键词:
AdultAgeAnorexia NervosaAttitudeAwardBehaviorBehavioralBody WeightBody mass indexChoice BehaviorChoices and ControlChronicClinicalClinical ResearchCognitionCognitiveComputing MethodologiesDataDecision MakingDevelopmentDiseaseDisease modelEtiologyEvidence based treatmentFailureFemaleFertilityFoodFrightGoalsIndividualIndividual DifferencesInterruptionInterventionKnowledgeLateralLinkMaintenanceMeasuresMedialMedicalMental disordersModelingNeurobehavioral ManifestationsNeurobiologyNeurocognitiveNeurosciencesOrganismOutcomePatternPerformancePopulationPopulation ControlPrefrontal CortexProbabilityProcessReportingResearchResourcesRiskScanningSecondary toServicesSignal TransductionSpecificitySubgroupSymptomsTestingTheoretical modelTimeTreatment outcomeUncertaintyUniversitiesVentral StriatumWeightWeight GainWorkagedbehavioral economicsbehavioral responsebiobehaviorcareerclinically relevantcomputational neurosciencecostdesigndietarydietary restrictioneffective interventionexperiencefollow-upfunctional disabilitygastrointestinalgraduate studentimprovedinsightinterestmortalityneuralneurobehavioralneurobehavioral testneuroimagingneuromechanismpsychologicreduce symptomsresponserestraintstandard careundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Anorexia nervosa (AN) is the deadliest of all mental illnesses and is associated with significant medical
consequences and functional impairment. Despite significant research efforts, the etiology of the disorder
remains unknown, and outcomes from existing psychological treatments remain suboptimal. Some prior work in
AN has suggested alterations in decision-making, sensitivity to risk, and altered activity in frontostriatal circuits
may be involved in the maintenance of the disorder. However, this work has been mixed in its findings, likely
secondary to limited consideration of subcomponents of decision-making and/or relevant contextual influences
on this process. Drawing from work in behavioral economics and computational neuroscience, alongside clinical
evidence that many outcomes related to food and weight are uncertain/ambiguous, we propose that the decision-
making profile of individuals with AN may be better characterized by ambiguity aversion, such that a sensitivity
toward ambiguous outcomes interrupts successful value-based decision-making and results in maintenance of
dietary restraint despite significant functional and personal cost. To test this hypothesis, we will gather behavioral
choice and neural data from females with AN, restricting type (n=65, ages 16-22) and healthy control (HC)
subjects (n=65) while completing a well-validated decision-making task that allows separation of risky and
ambiguous decisions. Additionally, the AN group will provide measures of symptoms at baseline and 6-month
follow-up to explore how performance on the task relates to the persistence of symptoms. We hypothesize that
the AN group will demonstrate increased ambiguity aversion compared to HC and choice behavior inconsistent
with prevailing models of value-based decision-making (Aim 1). On the neural level, we expect that, compared
to HC, individuals with AN will demonstrate differential activation in frontostriatal regions during ambiguous trials,
rather than risk (Aim 2). Lastly, we expect that neural and behavioral parameters gauging ambiguity aversion
will relate to BMI, dietary restriction, and cognitive symptoms of AN both cross-sectionally and over time, such
that individuals demonstrating greater aversion to ambiguous decisions will have lower body weights and greater
engagement in symptoms, supporting our hypothesized maintenance mechanism (Aim 3). Overall, the current
project will provide an important next step toward a more precise characterization of the cognitive profile of
individuals with AN. In pursuing this knowledge, consistent with the goal of the R15 AREA award, the current
project will simultaneously provide graduate and undergraduate students at Hofstra University with invaluable
hands-on experiences in neuroimaging, computational methods, and clinical research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: